Showing 133 to 144 of 171 results
Manas AI: AI-Powered Drug Discovery Startup Launches with $24.6 Million in Seed Funding
Reid Hoffman and Dr. Siddhartha Mukherjee launched Manas AI, a $24.6 million AI-powered drug discovery startup targeting aggressive cancers, aiming to significantly reduce development time and costs using proprietary chemical libraries and AI filters.
Manas AI: AI-Powered Drug Discovery Startup Launches with $24.6 Million in Seed Funding
Reid Hoffman and Dr. Siddhartha Mukherjee launched Manas AI, a $24.6 million AI-powered drug discovery startup targeting aggressive cancers, aiming to significantly reduce development time and costs using proprietary chemical libraries and AI filters.
Progress
44% Bias Score
Rising Cancer Rates Drive Employer Focus on Holistic Employee Support
The American Cancer Society predicts over 2 million new cancer cases in 2024, leading to increased healthcare costs; employers are responding by improving access to mental and physical healthcare, including programs like Calm Health's Tools to Cope with Cancer, which has a 4 out of 5 user rating.
Rising Cancer Rates Drive Employer Focus on Holistic Employee Support
The American Cancer Society predicts over 2 million new cancer cases in 2024, leading to increased healthcare costs; employers are responding by improving access to mental and physical healthcare, including programs like Calm Health's Tools to Cope with Cancer, which has a 4 out of 5 user rating.
Progress
36% Bias Score
Breakwater Study Shows Improved Outcomes for Colorectal Cancer Patients with BRAFV600 Mutations
A new study shows that a combined therapy of chemotherapy, encorafenib, and cetuximab significantly improves outcomes for colorectal cancer patients with BRAFV600 mutations, achieving a 68.7% response rate lasting over six months compared to 34.1% with standard chemotherapy.
Breakwater Study Shows Improved Outcomes for Colorectal Cancer Patients with BRAFV600 Mutations
A new study shows that a combined therapy of chemotherapy, encorafenib, and cetuximab significantly improves outcomes for colorectal cancer patients with BRAFV600 mutations, achieving a 68.7% response rate lasting over six months compared to 34.1% with standard chemotherapy.
Progress
40% Bias Score
Flash Therapy: A Revolutionary Cancer Treatment
Researchers at CERN are developing flash therapy, a new cancer treatment using proton beams to destroy tumors in milliseconds with minimal damage to healthy tissues, potentially replacing traditional radiation therapy and offering advantages for treating brain and other hard-to-reach cancers.
Flash Therapy: A Revolutionary Cancer Treatment
Researchers at CERN are developing flash therapy, a new cancer treatment using proton beams to destroy tumors in milliseconds with minimal damage to healthy tissues, potentially replacing traditional radiation therapy and offering advantages for treating brain and other hard-to-reach cancers.
Progress
48% Bias Score
CAR T-cell Therapy for Breast Cancer: Early Trials Show Promise, but Challenges Remain
Currently, 16 active phase I/II clinical trials are investigating CAR T-cell therapy for various solid tumors, including breast cancer, primarily in the US, focusing on safety and feasibility; results are preliminary, showing some encouraging but limited data, with no phase III trials yet.
CAR T-cell Therapy for Breast Cancer: Early Trials Show Promise, but Challenges Remain
Currently, 16 active phase I/II clinical trials are investigating CAR T-cell therapy for various solid tumors, including breast cancer, primarily in the US, focusing on safety and feasibility; results are preliminary, showing some encouraging but limited data, with no phase III trials yet.
Progress
40% Bias Score
Danielle Fishel Completes Cancer Treatment
Danielle Fishel, the "Boy Meets World" actress, announced the completion of her active cancer treatment for DCIS, a form of breast cancer, on her podcast, "Pod Meets World". She received radiation therapy but not surgery or chemotherapy and will now start Tamoxifen.
Danielle Fishel Completes Cancer Treatment
Danielle Fishel, the "Boy Meets World" actress, announced the completion of her active cancer treatment for DCIS, a form of breast cancer, on her podcast, "Pod Meets World". She received radiation therapy but not surgery or chemotherapy and will now start Tamoxifen.
Progress
8% Bias Score
mRNA Cancer Vaccines: Promising Trials, but No Approvals Yet
Despite initial hopes after the success of mRNA COVID-19 vaccines, no mRNA cancer vaccines have received approval yet; however, several are in clinical trials, showing potential for personalized cancer treatments but facing significant hurdles.
mRNA Cancer Vaccines: Promising Trials, but No Approvals Yet
Despite initial hopes after the success of mRNA COVID-19 vaccines, no mRNA cancer vaccines have received approval yet; however, several are in clinical trials, showing potential for personalized cancer treatments but facing significant hurdles.
Progress
32% Bias Score
Combating Social Isolation and Ageism in Spain: Initiatives and Impacts
This article details multiple Spanish social programs combating loneliness, ageism, and poverty, featuring individual stories and statistical data illustrating their impact on vulnerable populations.
Combating Social Isolation and Ageism in Spain: Initiatives and Impacts
This article details multiple Spanish social programs combating loneliness, ageism, and poverty, featuring individual stories and statistical data illustrating their impact on vulnerable populations.
Progress
28% Bias Score
England's Cancer Crisis: Regional Disparities and Urgent Need for Improved Care
A new analysis reveals a rising number of cancer cases in England, with 3.4 million people expected to be living with the disease by the end of 2024, highlighting regional disparities in incidence rates and the urgent need for improved cancer care.
England's Cancer Crisis: Regional Disparities and Urgent Need for Improved Care
A new analysis reveals a rising number of cancer cases in England, with 3.4 million people expected to be living with the disease by the end of 2024, highlighting regional disparities in incidence rates and the urgent need for improved cancer care.
Progress
48% Bias Score
Modified Bird Virus Shows Promise in Treating Multiple Cancers
A Chinese study showed a modified bird virus, NDV-GT, shrunk or stopped tumor growth in 22 of 23 patients with eight different advanced cancers in a trial; further trials are planned.
Modified Bird Virus Shows Promise in Treating Multiple Cancers
A Chinese study showed a modified bird virus, NDV-GT, shrunk or stopped tumor growth in 22 of 23 patients with eight different advanced cancers in a trial; further trials are planned.
Progress
40% Bias Score
Misdiagnosis Delays Cancer Treatment for Two-Year-Old
Two-year-old Gracie McHugh from Halifax, West Yorkshire, was misdiagnosed with a virus before a devastating acute lymphoblastic leukaemia (ALL) diagnosis in January 2023; after intensive treatment and participation in a clinical trial, she is nearing the end of her treatment, but faces potential lon...
Misdiagnosis Delays Cancer Treatment for Two-Year-Old
Two-year-old Gracie McHugh from Halifax, West Yorkshire, was misdiagnosed with a virus before a devastating acute lymphoblastic leukaemia (ALL) diagnosis in January 2023; after intensive treatment and participation in a clinical trial, she is nearing the end of her treatment, but faces potential lon...
Progress
24% Bias Score
New Ultrasound Method Shows 94% Accuracy in Detecting Prostate Cancer
A new ultrasound-based prostate cancer detection method developed at Heriot Watt University shows a 94% detection rate in early trials, potentially revolutionizing diagnosis and treatment due to its use of widely available equipment and improved accuracy.
New Ultrasound Method Shows 94% Accuracy in Detecting Prostate Cancer
A new ultrasound-based prostate cancer detection method developed at Heriot Watt University shows a 94% detection rate in early trials, potentially revolutionizing diagnosis and treatment due to its use of widely available equipment and improved accuracy.
Progress
36% Bias Score
Showing 133 to 144 of 171 results